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BACKGROUND
Esophageal stents can be used to treat benign esophageal 
disorders such as esophageal leaks, fistulas, refractory 
strictures and malignant conditions like locally unresectable 
or advanced metastatic cancer of the esophagus, those 
with poor functional status who can’t tolerate surgery or 
chemo radiotherapy, or those in whom previous treatment 
failed or those with locally recurrent disease. There are 
various complications post stent placement like chest pain, 
bleeding and stent migration. These complications depend 
on a number of factors like indication of stent placement, 
diameter/length and design of the stent.
STUDY AIMS
This study focused on assessing Boston Scientific (WallFlex) 
VS Merit Medical Endotek complication rates in benign and 
malignant conditions.
METHOD
In this retrospective study, patients who underwent 
esophageal stent placement for benign and malignant 
esophageal conditions between January 1, 2006 and 
December 12, 2016 were selected. Charts were reviewed 
to capture gender, indication of stent placement, stent 
length/diameter, age of the patient at the time of stent 
placement, length of hospital stay, physician performing a 
procedure and complications within 90 days of stent 
placement. Descriptive statistics including means were 
reported with the standard deviation for the continuous 
variables along with frequencies and percentages for all 
categorical variables.
RESULT
67 patients (71.6% male) underwent stent placement 
(WallFlex 49.3% and Merit 50.8%) for malignant (68.7%) 
mainly esophageal obstruction by primary esophageal 
cancer (89.1%) and benign causes (31.3%) mainly 
esophageal leak (66.7%). Merit and WallFlex used in 
malignant conditions were 82.4% and 54.6%, respectively, 
and in benign conditions were 17.7% and 45.5%, 
respectively. Mean age at which endoscopy was performed 
63.0 ± 11.8 years. Most common diameter used was 
23mm (74.2%) and length used was 120mm (38.8%). 
Complications post Merit and WallFlex placement were 
79.4% and 60.6%, respectively, with chest pain (67.7% 
and 48.5%) being the most common complaint followed by 
stent migration (29.4% and 18.2%) and bleeding (14.7% 
and 12.1%)
Complications with malignant and benign conditions were 
73.9% and 61.9%, respectively (specific complication data 
in Figure 1).
Complications with 19, 18 and 23mm diameters were 
75.0%, 66.7% and 69.4%, respectively. Complications with 
120, 150, 100, 15, 12, 10mm stent lengths were 84.6%, 
58.3%, 58.8%, 80.0%, 75.0% and 33.3%, respectively.
CONCLUSION
Our study showed that Merit stent was mainly used and 
major indication of stent placement was a malignant 
condition. Major complications were seen when the reason 
for stent placement was a malignant condition, diameter 
was 19mm, length was 120mm and use of Merit stent.
WallFlex Esophageal Stent 
Merit Medical Endotek
Figure 1
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